{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:40:11Z","timestamp":1773758411346,"version":"3.50.1"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"DOI":"10.1001\/jama.288.2.165","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T10:05:58Z","timestamp":1047981958000},"page":"165","source":"Crossref","is-referenced-by-count":23,"title":["Safety and Tolerability of Intermittent Rifampin\/Pyrazinamide for the Treatment of Latent Tuberculosis Infection in Prisoners"],"prefix":"10.1001","volume":"288","author":[{"given":"Richard E.","family":"Chaisson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Golub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2002,7,10]]},"reference":[{"key":"REF-JLT0710-4-1-1","doi-asserted-by":"crossref","unstructured":"NAHalseyJSCoberlyJDesormeauxRandomised trial of isoniazid versus rifampin and pyrazinamide for\nthe prevention of tuberculosis in HIV-1 infection.Lancet.1998;351:786-792.","DOI":"10.1016\/S0140-6736(97)06532-X"},{"key":"REF-JLT0710-4-1-2","doi-asserted-by":"crossref","unstructured":"FGordinREChaissonJPMattsRifampin and pyrazinamide vs isoniazid for prevention of tuberculosis\nin HIV-infected persons: an international randomized trial.JAMA.2000;283:1445-1450.","DOI":"10.1001\/jama.283.11.1445"},{"key":"REF-JLT0710-4-1-3","unstructured":"US Centers for Disease Control and PreventionUpdate: fatal and severe liver injuries associated with rifampin and\npyrazinamide for latent tuberculosis infection, and revisions in American\nThoracic Society\/CDC recommendations\u2014United States, 2001.MMWR Morb Mortal Wkly Rep.2001;50:733-735."},{"key":"REF-JLT0710-4-1-4","doi-asserted-by":"crossref","unstructured":"NNBockTRogersJRTapiaAcceptability of short-course rifampin and pyrazinamide treatment of\nlatent tuberculosis infection among jail inmates.Chest.2001;119:681-682.","DOI":"10.1378\/chest.119.3.833"},{"key":"REF-JLT0710-4-1-5","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/Centers for Disease Control and PreventionTargeted tuberculin testing and treatment of latent tuberculosis infection.Am J Respir Crit Care Med.2000;161:S221-S247.","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/1031953\/jlt0710.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:01:20Z","timestamp":1764954080000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1031953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,10]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7,10]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.288.2.165","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7,10]]}}}